Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History, a minor update to the page's version log that does not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now includes Revision: v3.3.3, and the footer no longer displays HHS Vulnerability Disclosure or Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedNew revision entry v3.3.2 appears in the record history, and the v3.2.0 entry is removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved a generic government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check77 days agoChange DetectedThe new screenshot shows only minor UI/layout updates to the Record History page, with no changes to study data or statuses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange Detected- Added a government-operating-status notice and an NIH Clinical Center update, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference11%

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.